AI MARKET SCANNING

Autolus Therapeutics plc

📅 Next Catalyst: Nov 10, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +0.59%
MAX GAP RECORD -10.67%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $AUTL
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 10, 2026 Earnings Release 2026-11-10 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 11, 2026 Earnings Release 2026-08-11 (BEFORE OPEN)
-1.45%
May 13, 2026 Earnings Release 2026-05-13 (BEFORE OPEN)
-0.63%
Mar 27, 2026 Earnings Release 2026-03-27 (BEFORE OPEN)
-6.20%
Nov 12, 2025 Earnings Release 2025-11-12 (BEFORE OPEN)
-10.67%
Aug 12, 2025 Earnings Release 2025-08-12 (BEFORE OPEN)
+1.21%
May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN)
+0.00%
Mar 20, 2025 Earnings Release 2025-03-20 (BEFORE OPEN)
+3.61%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.2%
Bullish Gaps (8)
Bearish Gaps (5)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $AUTL

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company offers AUCATZYL, a gene therapy product consisting of autologous T cells that are transduced with a lentiviral vector to express a novel anti-CD19…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗